BU-NOT-SET

CONTACT US
Nitrosamines analysis
  • Analytical chemistry
Nitrosamines analysis
Fact sheet
Enabling oral solid dosage form delivery of biologics
  • Biologics
  • Drug substance
oral biologics
Insight
Plasmid DNA manufacturing capabilities
  • Biologics
plasmid DNA manufacturing
Fact sheet
Leveraging analytics throughout development and manufacture to achieve commercial success
  • Analytical chemistry
  • Drug substance
development
Insight
2,300 solar panels installed at Recipharm’s Holmes Chapel
  • Sustainability
solar panels
Insight
Analysing prebiotic oligosaccharides for future product innovation
  • Analytical chemistry
  • Drug substance
Workers
White paper
Enhancing sterile processing for future vaccine programs
  • Industry trends
  • Manufacturing
Manufacturing
Insight
Increasing carbon emission transparency through SBTi contributions
  • Sustainability
SBTi
Insight
Single-use technologies are enabling increasing demand for biologics
  • Biologics
People
Insight
Insight
  • Manufacturing
Why outsourcing is key to bringing flexibility and capacity to the manufacture of oral solid dosage forms
Insight
  • Industry trends
Can bigger be better?
Insight
  • Industry trends
What does 2017 have in store for the pharma industry?
Insight
  • Industry trends
Reflecting on 2017 | the factors shaping our industry
Insight
  • Manufacturing
Protecting against counterfeiting with serialisation
Insight
  • Industry trends
Manufacturing Chemist CDMO roundtable – part two
Insight
  • Industry trends
Manufacturing Chemist CDMO roundtable – part one
Insight
  • Industry trends
  • Manufacturing
Increased drive to outsource manufacturing in life science
Insight
  • Manufacturing
Serialisation: the final countdown